TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer

Immunotherapy, a chemotherapy-free process, has emerged as a promising therapeutic strategy to prolong the overall survival (OS) of patients with non-small-cell lung cancer (NSCLC). However, effective stratification factors for immunotherapy remain unclear. The purpose of this study was to discuss t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jun, Zhong, Runbo, Lou, Yuqing, Hu, Minjuan, Yang, Zhengyu, Wang, Yanan, Chen, Ya, Zou, Benkun, Zhang, Wei, Wang, Huimin, Han, Baohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485033/
https://www.ncbi.nlm.nih.gov/pubmed/34603310
http://dx.doi.org/10.3389/fimmu.2021.732125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485033/
https://www.ncbi.nlm.nih.gov/pubmed/34603310
http://dx.doi.org/10.3389/fimmu.2021.732125

Ejemplares similares